Publications by authors named "M Mesbah"

Background: There are many percutaneous coronary approaches. The most commonly used one is the radial artery because of its lowest risk of adverse vascular events. However, it could not be an option in some situations as congenital radial artery hypoplasia and spasm.

View Article and Find Full Text PDF

Water deficit is a critical obstacle that devastatingly impacts rice production, particularly in arid regions under current climatic fluctuations. Accordingly, it is decisive to reinforce the drought tolerance of rice by employing sustainable approaches to enhance global food security. The present study aimed at exploring the effect of exogenous application using different biostimulants on physiological, morphological, and yield attributes of diverse rice genotypes under water deficit and well-watered conditions in 2-year field trial.

View Article and Find Full Text PDF

A 60-day study was carried out to determine the effect of dietary selenium nanoparticles (SeNP) on growth, digestive enzymes, and health status of Asian seabass (, 46.5 ± 0.2 g) juveniles reared in high saline water (48 ppt).

View Article and Find Full Text PDF

Background: It remains unclear which formulation of the corticosteroid regimen has the optimum efficacies on COVID-19 pneumonia.

Objectives: The aim of this study was to compare the clinical outcomes of 2 different regimens in the treatment of acute respiratory distress syndrome (ARDS) caused by COVID-19: Methylprednisolone at a dose of 1 mg/kg every 12 hours (low-dose group) and 1000 mg/day pulse therapy for 3 days following 1 mg/kg methylprednisolone every 12 hours (high-dose group).

Methods: In this randomized clinical trial, patients with mild to moderate ARDS due to COVID-19 were randomly assigned to receive either low-dose (n = 47) or high-dose (n = 48) intravenous methylprednisolone regimens.

View Article and Find Full Text PDF
Article Synopsis
  • Current Alzheimer's disease (AD) treatments mainly provide symptom relief without altering the disease's progression, prompting researchers to explore innovative therapies focused on inflammation and neuro-regeneration.
  • Recent FDA-approved anti-amyloid drugs like aducanumab and lecanemab show unclear effectiveness in real-world settings and have significant side effects, highlighting the need for better early-stage interventions.
  • Ongoing research includes strategies to target neuroinflammation, such as modifying immune responses, enhancing autophagy, and lifestyle interventions like diet and exercise, in hopes of preserving cognitive function.
View Article and Find Full Text PDF